Efficacy and Safety of Continuing Sitagliptin when Initiating Insulin Therapy in Subjects with Type 2 Diabetes Mellitus

DPP-4 inhibitors (DPP-4is) are often discontinued with initiation of insulin therapy but the impact of this discontinuation on efficacy and hypoglycemia has not been studied. In this double-blind trial the safety and efficacy of initiating insulin while continuing sitagliptin (SITA) was evaluated. E...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2018-07, Vol.67 (Supplement_1)
Hauptverfasser:	ROUSSEL, RONAN, DURAN-GARCIA, SANTIAGO, ZHANG, YILONG, SHAH, SUNERI, DARMIENTO, CAROLYN, RAVI SHANKAR, R., O'NEILL, EDWARD A., GOLM, GREGORY T., LAM, RAYMOND L., GANTZ, IRA, KAUFMAN, KEITH D., ENGEL, SAMUEL S.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!